• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
BOD 0.00% 2.4¢

BOD SCIENCE LIMITED - Announcements

Bod Science Limited is an Australia-based cannabis focused drug development and product... Bod Science Limited is an Australia-based cannabis focused drug development and product innovation company. The Company is focused on progressing research and development with a defined clinical trial pathway to commercialize and deliver products for consumer and medical markets. The principal activities of the Company are the development and distribution of therapeutic medicinal cannabis products based on good manufacturing practice (GMP) certified cannabis extracts for medical markets in Australia and the United Kingdom, as well as the development of cannabidiol (CBD) and hemp products for consumer markets in Australia, the United Kingdom, Europe, and United States. The Company’s segments include medical, over the counter cannabidiol/Hemp (OTC CBD/Hemp) and OTC Herbals. The Company offers products for health and wellness, joint/muscle pain and general wellbeing, and stress/anxiety and sleep. The Company also owns the Aqua Phase delivery technology.More

Announcements


BOD Annual Report to shareholders28/10/22 download Created with Sketch. 4.24MB
BOD Appendix 4G and Corporate Governance Statement28/10/22 download Created with Sketch. 506.66KB
BOD Notice of Annual General Meeting/Proxy Form28/10/22 download Created with Sketch. 666.45KB
BOD Quarterly Activities Report and Appendix 4CPRICE SENSITIVE27/10/22 download Created with Sketch. 442.49KB
BOD CEO presentation to South-West Connect Showcase20/10/22 download Created with Sketch. 2.73MB
BOD International patent application filed by Bod20/10/22 download Created with Sketch. 228.39KB
BOD Date of Annual General Meeting17/10/22 download Created with Sketch. 164.72KB
BOD Section 708A(5) cleansing notice14/10/22 download Created with Sketch. 76.11KB
BOD Application for quotation of securities - BOD14/10/22 download Created with Sketch. 25.29KB
BOD Notification regarding unquoted securities - BOD14/10/22 download Created with Sketch. 26.29KB
BOD Amended Change of Director's Interest Notice - George Livery13/10/22 download Created with Sketch. 271.94KB
BOD Change of Director's Interest Notice - David Baker13/10/22 download Created with Sketch. 253.22KB
BOD Change of Director's Interest Notice - George Livery13/10/22 download Created with Sketch. 177.77KB
BOD Apppendix 2A - Underwriting Offer13/10/22 download Created with Sketch. 352.13KB
BOD Sction 708A(5) secondary trading notice11/10/22 download Created with Sketch. 76KB
BOD Appendix 2A - Shortfall Offer11/10/22 download Created with Sketch. 351.47KB
BOD Application for quotation of securities - BOD06/10/22 download Created with Sketch. 24.97KB
BOD Successful completion of Entitlement OfferPRICE SENSITIVE04/10/22 download Created with Sketch. 208.81KB
BOD Application for quotation of securities - BOD30/09/22 download Created with Sketch. 25.36KB
BOD Appendix 3B - extended closing date for Entitlement Offer20/09/22 download Created with Sketch. 754.01KB
BOD Change in substantial holding20/09/22 download Created with Sketch. 253.8KB
BOD Extension of Closing Date for Entitlement Offer20/09/22 download Created with Sketch. 215.01KB
BOD Entitlement Offer Booklet09/09/22 download Created with Sketch. 2.94MB
BOD Entitlement Offer - Letter to Eligible Shareholders09/09/22 download Created with Sketch. 92.34KB
BOD Entitlement Offer - Letter to Ineligible Shareholders09/09/22 download Created with Sketch. 133.15KB
BOD Section 708A cleansing notice - Placement07/09/22 download Created with Sketch. 80.6KB
BOD Application for quotation of securities - BOD07/09/22 download Created with Sketch. 24.83KB
BOD Appendix 3B Entitlement Offer - amended issue date02/09/22 download Created with Sketch. 760.82KB
BOD Appendix 3B Entitlement Offer01/09/22 download Created with Sketch. 763.54KB
BOD Proposed issue of securities - BOD01/09/22 download Created with Sketch. 25.14KB
BOD Section 708AA(2) cleansing notice01/09/22 download Created with Sketch. 60.71KB
BOD Investor PresentationPRICE SENSITIVE01/09/22 download Created with Sketch. 4.64MB
BOD Capital raising and transformational acquisitionPRICE SENSITIVE01/09/22 download Created with Sketch. 291.49KB
BOD Appendix 4E and full year statutory accountsPRICE SENSITIVE30/08/22 download Created with Sketch. 1.33MB
BOD Bod to acquire Aqua PhasePRICE SENSITIVE30/08/22 download Created with Sketch. 200.21KB
BOD Trading HaltPRICE SENSITIVE30/08/22 download Created with Sketch. 281.01KB
BOD Bod awarded US Hemp Authority certificate for CBD extractPRICE SENSITIVE19/08/22 download Created with Sketch. 217.92KB
BOD Quarterly activities report and Appendix 4CPRICE SENSITIVE28/07/22 download Created with Sketch. 437.86KB
BOD CBD Schedule 3 product to be launched via SAS-B channelPRICE SENSITIVE23/06/22 download Created with Sketch. 216.32KB
BOD Study highlights efficacy of new medicinal cannabis productPRICE SENSITIVE25/05/22 download Created with Sketch. 227.45KB
BOD Final Director's Interest Notice17/05/22 download Created with Sketch. 194.73KB
BOD Non-Executive Chairman Transition17/05/22 download Created with Sketch. 193.81KB
BOD First patients enrolled for Schedule 3 CBD clinical trial10/05/22 download Created with Sketch. 229.52KB
BOD Quarterly Activities Report and Appendix 4CPRICE SENSITIVE29/04/22 download Created with Sketch. 434.28KB
BOD First patients enrolled for Long COVID study26/04/22 download Created with Sketch. 234.13KB
BOD Initial Director's Interest Notice - David Baker04/04/22 download Created with Sketch. 232.33KB
BOD Final Director's Interest Notice - Simon O'Loughlin04/04/22 download Created with Sketch. 209.79KB
BOD Appointment and resignation of Non-Executive Director04/04/22 download Created with Sketch. 194.56KB
BOD Half Year Activities ReportPRICE SENSITIVE25/02/22 download Created with Sketch. 248.63KB
BOD Half Year Accounts and Appendix 4DPRICE SENSITIVE25/02/22 download Created with Sketch. 663.78KB
BOD Novel food application accepted by UK Food Service AgencyPRICE SENSITIVE21/02/22 download Created with Sketch. 220.5KB
BOD Quarterly Activities Report and Quarterly Cash Flow ReportPRICE SENSITIVE31/01/22 download Created with Sketch. 432.35KB
BOD Ethics approval received for Schedule 3 clinical trialPRICE SENSITIVE24/01/22 download Created with Sketch. 234.22KB
BOD Authorisation secured for UK based long covid clinical trialPRICE SENSITIVE17/01/22 download Created with Sketch. 260.31KB
BOD Notification regarding unquoted securities - BOD24/12/21 download Created with Sketch. 27.34KB
BOD Results of Meeting22/11/21 download Created with Sketch. 203.82KB
BOD CEO presentation to AGM22/11/21 download Created with Sketch. 2.95MB
BOD Appendix 4G and Corporate Governance Statement29/10/21 download Created with Sketch. 550.41KB
BOD Annual Report to shareholders29/10/21 download Created with Sketch. 3.29MB
BOD Quarterly Activities Report and Appendix 4CPRICE SENSITIVE27/10/21 download Created with Sketch. 435.31KB
BOD Notice of Annual General Meeting/Proxy Form22/10/21 download Created with Sketch. 873.21KB
BOD Change of ASX code to BOD15/10/21 download Created with Sketch. 144.89KB
BOD BOD to conduct Schedule 3 clinical trial of new CBD productPRICE SENSITIVE22/09/21 download Created with Sketch. 232.32KB
BOD Change in substantial holding27/08/21 download Created with Sketch. 96.45KB
BOD Investor Presentation25/08/21 download Created with Sketch. 3.81MB
BOD Record revenue achieved during FY2021PRICE SENSITIVE23/08/21 download Created with Sketch. 149.88KB
BOD Appendix 4E and Full Year Statutory AccountsPRICE SENSITIVE23/08/21 download Created with Sketch. 1.17MB
BOD Appointment of leading executive as Chief Financial Officer02/08/21 download Created with Sketch. 516.36KB
BOD Final Director's Interest Notice21/07/21 download Created with Sketch. 133.52KB
BOD Initial Director's Interest Notice - Hanno Cappon21/07/21 download Created with Sketch. 132.76KB
BOD Non-Executive Director resignation and appointment21/07/21 download Created with Sketch. 512.13KB
BOD Quarterly Activities Report and Appendix 4CPRICE SENSITIVE15/07/21 download Created with Sketch. 716.19KB
BOD 212% increase in medicinal cannabis product sales in FY2021PRICE SENSITIVE01/07/21 download Created with Sketch. 603.42KB
BOD Bod broadens UK sales footprintPRICE SENSITIVE17/06/21 download Created with Sketch. 692.49KB
BOD Results of Meeting04/06/21 download Created with Sketch. 471.52KB
BOD Launch of new medicinal cannabis product and UK updatePRICE SENSITIVE18/05/21 download Created with Sketch. 607.79KB
BOD Highest ever monthly sales of medicinal cannabis productsPRICE SENSITIVE10/05/21 download Created with Sketch. 571.35KB
BOD Notice of Extraordinary General Meeting/Proxy Form30/04/21 download Created with Sketch. 490.71KB
BOD Quarterly acitivities report and Appendix 4CPRICE SENSITIVE22/04/21 download Created with Sketch. 905.25KB
BOD Appointment of leading executive as Chief Financial Officer12/04/21 download Created with Sketch. 543.25KB
BOD Bod secures first binding purchase order for US marketPRICE SENSITIVE07/04/21 download Created with Sketch. 537.77KB
BOD Record medicinal cannabis sales achieved during Q3 FY2021PRICE SENSITIVE31/03/21 download Created with Sketch. 597.89KB
BOD Collaboration agreement with Drug Science for long-COVID18/03/21 download Created with Sketch. 598.72KB
BOD Strong half driven by international expansionPRICE SENSITIVE25/02/21 download Created with Sketch. 602.96KB
BOD Half Year Accounts and Appendix 4DPRICE SENSITIVE25/02/21 download Created with Sketch. 2MB
BOD Amendment to 30 June 2020 financial statements24/02/21 download Created with Sketch. 6.36MB
BOD Resignation of Chief Financial Officer19/02/21 download Created with Sketch. 502.24KB
BOD Quarterly Activities Report and Appendix 4CPRICE SENSITIVE28/01/21 download Created with Sketch. 756.88KB
BOD Bod delivers record attributable sales in Q2 FY2021PRICE SENSITIVE18/01/21 download Created with Sketch. 539.96KB
BOD Bod achieves strong second half medicinal cannabis salesPRICE SENSITIVE07/01/21 download Created with Sketch. 566.84KB
BOD Change of Director Interest Notices - J Patterson and A Bedi31/12/20 download Created with Sketch. 382.34KB
BOD Appendix 3G24/12/20 download Created with Sketch. 284.11KB
BOD Section 708A cleansing notice22/12/20 download Created with Sketch. 500.28KB
BOD $871,413 in binding orders secured for the Italian marketPRICE SENSITIVE22/12/20 download Created with Sketch. 533.45KB
BOD Appendix 2A18/12/20 download Created with Sketch. 275.49KB
BOD Medical advisory board formed to capitalise on TGA decisionPRICE SENSITIVE16/12/20 download Created with Sketch. 556.6KB
BOD Proposed issue of Securities - BDAPRICE SENSITIVE11/12/20 download Created with Sketch. 25.23KB
BOD Bod secures commitments to raise $8m via private placementPRICE SENSITIVE11/12/20 download Created with Sketch. 519.91KB
BOD Trading HaltPRICE SENSITIVE10/12/20 download Created with Sketch. 561.12KB
BOD Bod to benefit from US push to decriminalise cannabisPRICE SENSITIVE07/12/20 download Created with Sketch. 533.91KB
BOD Annual Report to shareholders
28/10/22 download Created with Sketch. 4.24MB
BOD Appendix 4G and Corporate Governance Statement
28/10/22 download Created with Sketch. 506.66KB
BOD Notice of Annual General Meeting/Proxy Form
28/10/22 download Created with Sketch. 666.45KB
BOD Quarterly Activities Report and Appendix 4C
27/10/22PRICE SENSITIVE download Created with Sketch. 442.49KB
BOD CEO presentation to South-West Connect Showcase
20/10/22 download Created with Sketch. 2.73MB
BOD International patent application filed by Bod
20/10/22 download Created with Sketch. 228.39KB
BOD Date of Annual General Meeting
17/10/22 download Created with Sketch. 164.72KB
BOD Section 708A(5) cleansing notice
14/10/22 download Created with Sketch. 76.11KB
BOD Application for quotation of securities - BOD
14/10/22 download Created with Sketch. 25.29KB
BOD Notification regarding unquoted securities - BOD
14/10/22 download Created with Sketch. 26.29KB
BOD Amended Change of Director's Interest Notice - George Livery
13/10/22 download Created with Sketch. 271.94KB
BOD Change of Director's Interest Notice - David Baker
13/10/22 download Created with Sketch. 253.22KB
BOD Change of Director's Interest Notice - George Livery
13/10/22 download Created with Sketch. 177.77KB
BOD Apppendix 2A - Underwriting Offer
13/10/22 download Created with Sketch. 352.13KB
BOD Sction 708A(5) secondary trading notice
11/10/22 download Created with Sketch. 76KB
BOD Appendix 2A - Shortfall Offer
11/10/22 download Created with Sketch. 351.47KB
BOD Application for quotation of securities - BOD
06/10/22 download Created with Sketch. 24.97KB
BOD Successful completion of Entitlement Offer
04/10/22PRICE SENSITIVE download Created with Sketch. 208.81KB
BOD Application for quotation of securities - BOD
30/09/22 download Created with Sketch. 25.36KB
BOD Appendix 3B - extended closing date for Entitlement Offer
20/09/22 download Created with Sketch. 754.01KB
BOD Change in substantial holding
20/09/22 download Created with Sketch. 253.8KB
BOD Extension of Closing Date for Entitlement Offer
20/09/22 download Created with Sketch. 215.01KB
BOD Entitlement Offer Booklet
09/09/22 download Created with Sketch. 2.94MB
BOD Entitlement Offer - Letter to Eligible Shareholders
09/09/22 download Created with Sketch. 92.34KB
BOD Entitlement Offer - Letter to Ineligible Shareholders
09/09/22 download Created with Sketch. 133.15KB
BOD Section 708A cleansing notice - Placement
07/09/22 download Created with Sketch. 80.6KB
BOD Application for quotation of securities - BOD
07/09/22 download Created with Sketch. 24.83KB
BOD Appendix 3B Entitlement Offer - amended issue date
02/09/22 download Created with Sketch. 760.82KB
BOD Appendix 3B Entitlement Offer
01/09/22 download Created with Sketch. 763.54KB
BOD Proposed issue of securities - BOD
01/09/22 download Created with Sketch. 25.14KB
BOD Section 708AA(2) cleansing notice
01/09/22 download Created with Sketch. 60.71KB
BOD Investor Presentation
01/09/22PRICE SENSITIVE download Created with Sketch. 4.64MB
BOD Capital raising and transformational acquisition
01/09/22PRICE SENSITIVE download Created with Sketch. 291.49KB
BOD Appendix 4E and full year statutory accounts
30/08/22PRICE SENSITIVE download Created with Sketch. 1.33MB
BOD Bod to acquire Aqua Phase
30/08/22PRICE SENSITIVE download Created with Sketch. 200.21KB
BOD Trading Halt
30/08/22PRICE SENSITIVE download Created with Sketch. 281.01KB
BOD Bod awarded US Hemp Authority certificate for CBD extract
19/08/22PRICE SENSITIVE download Created with Sketch. 217.92KB
BOD Quarterly activities report and Appendix 4C
28/07/22PRICE SENSITIVE download Created with Sketch. 437.86KB
BOD CBD Schedule 3 product to be launched via SAS-B channel
23/06/22PRICE SENSITIVE download Created with Sketch. 216.32KB
BOD Study highlights efficacy of new medicinal cannabis product
25/05/22PRICE SENSITIVE download Created with Sketch. 227.45KB
BOD Final Director's Interest Notice
17/05/22 download Created with Sketch. 194.73KB
BOD Non-Executive Chairman Transition
17/05/22 download Created with Sketch. 193.81KB
BOD First patients enrolled for Schedule 3 CBD clinical trial
10/05/22 download Created with Sketch. 229.52KB
BOD Quarterly Activities Report and Appendix 4C
29/04/22PRICE SENSITIVE download Created with Sketch. 434.28KB
BOD First patients enrolled for Long COVID study
26/04/22 download Created with Sketch. 234.13KB
BOD Initial Director's Interest Notice - David Baker
04/04/22 download Created with Sketch. 232.33KB
BOD Final Director's Interest Notice - Simon O'Loughlin
04/04/22 download Created with Sketch. 209.79KB
BOD Appointment and resignation of Non-Executive Director
04/04/22 download Created with Sketch. 194.56KB
BOD Half Year Activities Report
25/02/22PRICE SENSITIVE download Created with Sketch. 248.63KB
BOD Half Year Accounts and Appendix 4D
25/02/22PRICE SENSITIVE download Created with Sketch. 663.78KB
BOD Novel food application accepted by UK Food Service Agency
21/02/22PRICE SENSITIVE download Created with Sketch. 220.5KB
BOD Quarterly Activities Report and Quarterly Cash Flow Report
31/01/22PRICE SENSITIVE download Created with Sketch. 432.35KB
BOD Ethics approval received for Schedule 3 clinical trial
24/01/22PRICE SENSITIVE download Created with Sketch. 234.22KB
BOD Authorisation secured for UK based long covid clinical trial
17/01/22PRICE SENSITIVE download Created with Sketch. 260.31KB
BOD Notification regarding unquoted securities - BOD
24/12/21 download Created with Sketch. 27.34KB
BOD Results of Meeting
22/11/21 download Created with Sketch. 203.82KB
BOD CEO presentation to AGM
22/11/21 download Created with Sketch. 2.95MB
BOD Appendix 4G and Corporate Governance Statement
29/10/21 download Created with Sketch. 550.41KB
BOD Annual Report to shareholders
29/10/21 download Created with Sketch. 3.29MB
BOD Quarterly Activities Report and Appendix 4C
27/10/21PRICE SENSITIVE download Created with Sketch. 435.31KB
BOD Notice of Annual General Meeting/Proxy Form
22/10/21 download Created with Sketch. 873.21KB
BOD Change of ASX code to BOD
15/10/21 download Created with Sketch. 144.89KB
BOD BOD to conduct Schedule 3 clinical trial of new CBD product
22/09/21PRICE SENSITIVE download Created with Sketch. 232.32KB
BOD Change in substantial holding
27/08/21 download Created with Sketch. 96.45KB
BOD Investor Presentation
25/08/21 download Created with Sketch. 3.81MB
BOD Record revenue achieved during FY2021
23/08/21PRICE SENSITIVE download Created with Sketch. 149.88KB
BOD Appendix 4E and Full Year Statutory Accounts
23/08/21PRICE SENSITIVE download Created with Sketch. 1.17MB
BOD Appointment of leading executive as Chief Financial Officer
02/08/21 download Created with Sketch. 516.36KB
BOD Final Director's Interest Notice
21/07/21 download Created with Sketch. 133.52KB
BOD Initial Director's Interest Notice - Hanno Cappon
21/07/21 download Created with Sketch. 132.76KB
BOD Non-Executive Director resignation and appointment
21/07/21 download Created with Sketch. 512.13KB
BOD Quarterly Activities Report and Appendix 4C
15/07/21PRICE SENSITIVE download Created with Sketch. 716.19KB
BOD 212% increase in medicinal cannabis product sales in FY2021
01/07/21PRICE SENSITIVE download Created with Sketch. 603.42KB
BOD Bod broadens UK sales footprint
17/06/21PRICE SENSITIVE download Created with Sketch. 692.49KB
BOD Results of Meeting
04/06/21 download Created with Sketch. 471.52KB
BOD Launch of new medicinal cannabis product and UK update
18/05/21PRICE SENSITIVE download Created with Sketch. 607.79KB
BOD Highest ever monthly sales of medicinal cannabis products
10/05/21PRICE SENSITIVE download Created with Sketch. 571.35KB
BOD Notice of Extraordinary General Meeting/Proxy Form
30/04/21 download Created with Sketch. 490.71KB
BOD Quarterly acitivities report and Appendix 4C
22/04/21PRICE SENSITIVE download Created with Sketch. 905.25KB
BOD Appointment of leading executive as Chief Financial Officer
12/04/21 download Created with Sketch. 543.25KB
BOD Bod secures first binding purchase order for US market
07/04/21PRICE SENSITIVE download Created with Sketch. 537.77KB
BOD Record medicinal cannabis sales achieved during Q3 FY2021
31/03/21PRICE SENSITIVE download Created with Sketch. 597.89KB
BOD Collaboration agreement with Drug Science for long-COVID
18/03/21 download Created with Sketch. 598.72KB
BOD Strong half driven by international expansion
25/02/21PRICE SENSITIVE download Created with Sketch. 602.96KB
BOD Half Year Accounts and Appendix 4D
25/02/21PRICE SENSITIVE download Created with Sketch. 2MB
BOD Amendment to 30 June 2020 financial statements
24/02/21 download Created with Sketch. 6.36MB
BOD Resignation of Chief Financial Officer
19/02/21 download Created with Sketch. 502.24KB
BOD Quarterly Activities Report and Appendix 4C
28/01/21PRICE SENSITIVE download Created with Sketch. 756.88KB
BOD Bod delivers record attributable sales in Q2 FY2021
18/01/21PRICE SENSITIVE download Created with Sketch. 539.96KB
BOD Bod achieves strong second half medicinal cannabis sales
07/01/21PRICE SENSITIVE download Created with Sketch. 566.84KB
BOD Change of Director Interest Notices - J Patterson and A Bedi
31/12/20 download Created with Sketch. 382.34KB
BOD Appendix 3G
24/12/20 download Created with Sketch. 284.11KB
BOD Section 708A cleansing notice
22/12/20 download Created with Sketch. 500.28KB
BOD $871,413 in binding orders secured for the Italian market
22/12/20PRICE SENSITIVE download Created with Sketch. 533.45KB
BOD Appendix 2A
18/12/20 download Created with Sketch. 275.49KB
BOD Medical advisory board formed to capitalise on TGA decision
16/12/20PRICE SENSITIVE download Created with Sketch. 556.6KB
BOD Proposed issue of Securities - BDA
11/12/20PRICE SENSITIVE download Created with Sketch. 25.23KB
BOD Bod secures commitments to raise $8m via private placement
11/12/20PRICE SENSITIVE download Created with Sketch. 519.91KB
BOD Trading Halt
10/12/20PRICE SENSITIVE download Created with Sketch. 561.12KB
BOD Bod to benefit from US push to decriminalise cannabis
07/12/20PRICE SENSITIVE download Created with Sketch. 533.91KB
(20min delay)
Last
2.4¢
Change
0.000(0.00%)
Mkt cap ! $4.256M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0
BOD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.